Van Bockstaele D R, Nijs G, Lenjou M, Bosmans E, Vanham G, Rodrigus I, Berneman Z N
University of Antwerp (UIA/UZA), Laboratory of Haematology, Edegem, Belgium.
Ann Hematol. 2000 Dec;79(12):667-71. doi: 10.1007/s002770000214.
It has previously been shown that gp130 and c-kit signalling synergize for the ex vivo expansion of human cord blood (CB) CD34+ haematopoietic progenitor cells. We were interested in evaluating this synergy within an ontogenetically different haematopoietic tissue [i.e. adult bone marrow (BM)] and on a more primitive progenitor subset (i.e. CD34+ CD38-cells), which are highly enriched for pre-colony forming unit (CFU) cells. These cells were plated out in a primary liquid culture supplemented with either interleukin (IL)-6+stem cell factor (SCF), IL-6+ SCF+soluble IL-6 receptor (sIL-6R), IL-6+SCF+sIL-6R+IL3+IL-1 or SCF+IL-3+IL-6+IL-1. Cell counting after liquid culture revealed an absolute expansion of 2.2-, 4.1-, 89.5- and 65.7-fold compared with initial cell input for the four-cytokine combinations, respectively. The secondary read-out assay revealed that this cell expansion in the liquid culture also resulted in CFU generation, with absolute cloning efficiencies of 0.002, 0.024, 12.13 and 7.73 (per cell initially present) for the respective cytokine combinations. These results indicate that gp130 and c-kit signalling alone (i.e. using IL6+SCF+sIL-6R), in terms of both cell number and CFU generation, insufficiently stimulate primitive adult BM CD34+CD38- haematopoietic cells in order to reach a CFU generation comparable with that obtained after multifactor stimulation. Adding sIL-6R to the multifactor stimulation and compared with this multifactor stimulation, a 1.7-fold synergy in terms of cell expansion and a 3.0-fold synergy in terms of CFU generation are obtained. The sIL-6R/IL-6 complex thus has a narrower spectrum of action on primitive adult BM CD34+CD38- cells than on CB CD34+ cells.
先前的研究表明,gp130和c-kit信号协同作用可使人脐带血(CB)CD34+造血祖细胞在体外扩增。我们感兴趣的是在发育上不同的造血组织[即成人骨髓(BM)]中以及在更原始的祖细胞亚群[即CD34+ CD38-细胞,其富含集落形成单位前体细胞(CFU)]中评估这种协同作用。将这些细胞接种在补充有白细胞介素(IL)-6+干细胞因子(SCF)、IL-6+ SCF+可溶性IL-6受体(sIL-6R)、IL-6+SCF+sIL-6R+IL3+IL-1或SCF+IL-3+IL-6+IL-1的原代液体培养物中。液体培养后的细胞计数显示,与四种细胞因子组合的初始细胞输入相比,绝对扩增倍数分别为2.2倍、4.1倍、89.5倍和65.7倍。二次检测显示,液体培养中的这种细胞扩增也导致了CFU的产生,各细胞因子组合的绝对克隆效率分别为0.002、0.024、12.13和7.73(相对于最初存在的每个细胞)。这些结果表明,仅gp130和c-kit信号(即使用IL6+SCF+sIL-6R),就细胞数量和CFU产生而言,不足以充分刺激原始成人BM CD34+CD38-造血细胞以达到与多因素刺激后相当的CFU产生。将sIL-6R添加到多因素刺激中并与该多因素刺激相比,在细胞扩增方面获得了1.7倍的协同作用,在CFU产生方面获得了3.0倍的协同作用。因此,sIL-6R/IL-6复合物对原始成人BM CD34+CD38-细胞的作用谱比对CB CD34+细胞的作用谱更窄。